Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Clinical Pharmacology|September 13, 2014
Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre studyLinda Amundstuen Reppe, Olav Spigset, Ylva Böttiger, et al.
Clinical Therapeutics|July 3, 2016
Relationship Between Time Consumption and Quality of Responses to Drug-related Queries: A Study From Seven Drug Information Centers in ScandinaviaLinda Amundstuen Reppe, Stian Lydersen, Jan Schjøtt, et al.
British Journal of Haematology|July 28, 2017
Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the Öresund Region, ScandinaviaEva Leinøe, Eva Zetterberg, Savvas Kinalis, et al.
Ugeskrift for Laeger|June 10, 2020
[Venous thromboembolism in patients with COVID-19]Maja Hellfritzsch, Thomas Kümler, Anette Tarp Hansen, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2026
Etranacogene dezaparvovec in people with hemophilia B and without adeno-associated virus serotype 5 neutralizing antibodies: a 4-year subgroup analysis of the Health Outcomes with Padua Gene; Evaluation in Hemophilia B (HOPE-B) trialPriyanka Raheja, Niamh O'Connell, Peter Verhamme, et al.
British Journal of Haematology|April 21, 2018
Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphomaKatrine S Fridthjof, Peter Kampmann, Anne Dünweber, et al.
Therapeutic Advances in Hematology|October 20, 2023
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic contextJan Astermark, Fariba Baghaei, Karin Strandberg, et al.
Blood|December 17, 2017
Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia BWolfgang Miesbach, Karina Meijer, Michiel Coppens, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2024
Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia BNiamh O'Connell, Paul van der Valk, Sandra Le Quellec, et al.
Blood|March 7, 2024
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trialGili Kenet, Beatrice Nolan, Bulent Zulfikar, et al.
Pageof 4